Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Targeting acetate metabolism: Achilles’ nightmare

British Journal of Cancer volume 124, pages 1900–1901 (2021)Cite this article

Subjects

Summary

Recent advances in our understanding of tumour heterogeneity alongside studies investigating altered metabolism within transformed tissue have identified metabolic pathways critical to cancer cell survival. Leveraging this information presents a promising new avenue for the generation of cancer-specific therapeutics and improved patient outcomes.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Targeting ACSS2 in human pathologies.

References

  1. Schug, Z. T., Vande Voorde, J. & Gottlieb, E. The metabolic fate of acetate in cancer. Nat. Rev. Cancer 16, 708–717 (2016).

    Article  CAS  Google Scholar 

  2. Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57–71 (2015).

    Article  CAS  Google Scholar 

  3. Bulusu, V., Tumanov, S., Michalopoulou, E., van den Broek, N. J., MacKay, G., Nixon, C. et al. Acetate recapturing by nuclear Acetyl-CoA synthetase 2 prevents loss of histone acetylation during oxygen and serum limitation. Cell Rep. 18, 647–658 (2017).

    Article  CAS  Google Scholar 

  4. Comerford, S. A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A. K. et al. Acetate dependence of tumors. Cell 159, 1591–1602 (2014).

    Article  CAS  Google Scholar 

  5. Li, Z., Liu, H., He, J., Wang, Z., Yin, Z., You, G. et al. Acetyl-CoA synthetase 2: a critical linkage in obesity-induced tumorigenesis in myeloma. Cell Metab. 33, 78–93 e7 (2021).

    Article  CAS  Google Scholar 

  6. Miller, K. D., Pniewski, K., Perry, C. E., Papp, S. B., Shaffer, J. D., Velasco-Silva, J. N. et al. Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast cancer growth. Cancer Res. 81, 1252–1264 (2021).

  7. Huang, Z., Zhang, M., Plec, A. A., Estill, S. J., Cai, L., Repa, J. J. et al. ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism. Proc. Natl Acad. Sci. USA 115, E9499–E9506 (2018).

    Article  CAS  Google Scholar 

  8. Zhao, S., Jang, C., Liu, J., Uehara, K., Gilbert, M., Izzo, L. et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature 579, 586–591 (2020).

    Article  CAS  Google Scholar 

  9. Mews, P., Egervari, G., Nativio, R., Sidoli, S., Donahue, G., Lombroso, S. I. et al. Alcohol metabolism contributes to brain histone acetylation. Nature 574, 717–721 (2019).

    Article  CAS  Google Scholar 

  10. Oyama, N., Okazawa, H., Kusukawa, N., Kaneda, T., Miwa, Y., Akino, H. et al. 11C-acetate PET imaging for renal cell carcinoma. Eur. J. Nucl. Med. Mol. Imaging 36, 422–427 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA, USA

    Katelyn D. Miller & Zachary T. Schug

Authors
  1. Katelyn D. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zachary T. Schug
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.D.M. and Z.T.S. generated the figures and wrote the manuscript.

Corresponding author

Correspondence to Zachary T. Schug.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent to publish

Not applicable.

Data availability

Not applicable.

Competing interests

The authors declare no competing interests.

Funding information

This work was supported by grants from NIH NCI DP2 CA249950-01 (Z.T.S.), NIH NCI P01 CA114046-12, Susan G. Komen® CCR19608782 (Z.T.S.), the V Foundation for Cancer Research (Z.T.S.) and NIH NCI T32 CA009171-44 (K.D.M.).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, K.D., Schug, Z.T. Targeting acetate metabolism: Achilles’ nightmare. Br J Cancer 124, 1900–1901 (2021). https://doi.org/10.1038/s41416-021-01345-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-021-01345-6

This article is cited by

Search

Advanced search

Quick links